Order Article Reprints

Ćeriman Krstić V, Samardžić N, Popević S, Stević R, Ilić B, Gajić M, Čolić N, Lukić K, Milošević Maračić B, Poparić Banđur B, et al. Efficacy of Durvalumab Consolidation Therapy After Sequential Chemoradiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer—Experience from the Daily Hospital of Clinic for Pulmonology, University Clinical Center of Serbia. Biomedicines. 2025; 13(4):892. https://doi.org/10.3390/biomedicines13040892

Ćeriman Krstić, Vesna, Natalija Samardžić, Spasoje Popević, Ruža Stević, Branislav Ilić, Milija Gajić, Nikola Čolić, Katarina Lukić, Brankica Milošević Maračić, Bojana Poparić Banđur, and et al. 2025. "Efficacy of Durvalumab Consolidation Therapy After Sequential Chemoradiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer—Experience from the Daily Hospital of Clinic for Pulmonology, University Clinical Center of Serbia" Biomedicines 13, no. 4: 892. https://doi.org/10.3390/biomedicines13040892

Ćeriman Krstić, V., Samardžić, N., Popević, S., Stević, R., Ilić, B., Gajić, M., Čolić, N., Lukić, K., Milošević Maračić, B., Poparić Banđur, B., Šeha, B., Radončić, D., & Milin Lazović, J. (2025). Efficacy of Durvalumab Consolidation Therapy After Sequential Chemoradiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer—Experience from the Daily Hospital of Clinic for Pulmonology, University Clinical Center of Serbia. Biomedicines, 13(4), 892. https://doi.org/10.3390/biomedicines13040892